K-Ras resides at the plasma membrane (PM) where it promotes cell survival and proliferation. Now, Trever Bivona, Mark Philips (New York University, New York, NY), and colleagues find that fluorescent K-Ras moves to internal cell membranes within a few minutes after activating protein kinase C (PKC), with deadly consequences.

![K-Ras (green) moves to mitochondria (red) when phosphorylated (right).\
PHILIPS/ELSEVIER](jcb172786af01){#fig1}

Philips\' group happened to stimulate GFP-labeled T cells for an unrelated experiment. "Before our eyes, K-Ras shot off the membrane and into the cell interior," says Philips. K-Ras is attached peripherally to the PM by a farnesyl lipid group and an adjacent polybasic sequence. The team hypothesized that phosphorylation by PKC within the polybasic region acted like a switch, neutralizing the positive charge and releasing K-Ras from the PM. Indeed, blocking this serine-181 phosphorylation by PKC prevented K-Ras internalization.

A phosphate-mimicking Glu-181 mutant gave another shocking result. Cells expressing this K-Ras construct died off rapidly by apoptosis, as internalized K-Ras inhabited ER, Golgi, and---more importantly---mitochondrial membranes.

The outer mitochondrial membrane hosts apoptosis regulators such as the Bcl-2 family members. Philips\' group found that the PKC-phosphorylated K-Ras interacted with Bcl-X[l]{.smallcaps} at mitochondrial membranes to promote apoptosis. Human T cells lacking K-Ras were resistant to activation-induced apoptosis.

Although Bcl-X[l]{.smallcaps} is normally antiapoptotic, the group proposes that K-Ras either sequesters Bcl-X[l]{.smallcaps} or converts it to a proapoptotic molecule.

Mutated Ras proteins are known to drive uncontrolled cell proliferation in 30 percent of human cancers. PKC agonists may be a possible strategy for treating such cancers, as the group found that oncogenic K-Ras also moved to the mitochondria when phosphorylated by PKC. Furthermore, K-Ras--driven tumors treated with the PKC agonist bryostatin-1 underwent apoptosis. PKC agonists such as bryostatin "cause K-Ras to fall off the plasma membrane," says Philips, "and it goes from being a molecule that drives cell growth to one that kills the cell instead."![](rr_end.jpg)
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